The role of NR4A1 in the TME has been further recognized with in vivo studies of tumor metastatic spreading models in wild-type (NR4A1+/+) mice and NR4A1−/− mice (Hanna et al., 2015; Li et al., 2017). This evidence concerns the gene NR4A1 and neoplasm.